Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-10-19
1991-06-18
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
4352351, 435236, 435237, 435238, A61K 3912, C12N 700
Patent
active
050248367
ABSTRACT:
The invention comprises a lyophilized live herpes virus vaccine that comprises from about 0.5% to about 8% moisture.
REFERENCES:
patent: 3961046 (1976-06-01), Cerini
patent: 4000256 (1976-12-01), Hilleman et al.
patent: 4273762 (1981-06-01), McAleer et al.
patent: 4324861 (1982-04-01), Kan
patent: 4337242 (1982-06-01), Markus et al.
patent: 4351827 (1982-09-01), Bijlenga
patent: 4622222 (1986-11-01), Horvath et al.
Phillips et al., "A Study of Water Binding in Lyophilized Viral Vaccine Systems", Chemical Abstracts, p. 368, vol. 95, Ref. #138440m, 1981.
Phillips et al., "A Study of Water Binding in Lyophilized Viral Systems", Cryobiology, vol. 18, No. 4, pp. 414-419, 1981.
Biological Abstract 83014029.
Maigetter Robert Z.
Markus Henry Z.
McAleer William J.
Caruso Charles M.
Merck & Co. , Inc.
Meredith Roy D.
Mohamed Abdel A.
Moskowitz Margaret
LandOfFree
Stable lyophilized live herpes virus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable lyophilized live herpes virus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable lyophilized live herpes virus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-144771